"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation". / Wareham, Neval E; Li, Qiuju; Sengeløv, Henrik; Da Cunha-Bang, Caspar; Gustafsson, Finn; Heilmann, Carsten; Perch, Michael; Rasmussen, Allan; Sørensen, Søren Schwartz; Mocroft, Amanda; Lundgren, Jens D.
I: Journal of Cancer Research and Clinical Oncology, Bind 145, Nr. 12, 12.2019, s. 3125-3135.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"
AU - Wareham, Neval E
AU - Li, Qiuju
AU - Sengeløv, Henrik
AU - Da Cunha-Bang, Caspar
AU - Gustafsson, Finn
AU - Heilmann, Carsten
AU - Perch, Michael
AU - Rasmussen, Allan
AU - Sørensen, Søren Schwartz
AU - Mocroft, Amanda
AU - Lundgren, Jens D
PY - 2019/12
Y1 - 2019/12
N2 - PURPOSE: Solid organ (SOT) and allogeneic haematopoietic stem cell (HSCT) transplant recipients have elevated risks of de novo or secondary cancer. We explored risk factors hereof.METHODS: Among SOT and HSCT between January 2004 and December 2014, standardised incidence ratio (SIR) of de novo/secondary cancer compared with the Danish population was determined and risk factors were identified using Poisson regression.RESULTS: During a median of 3.4 (IQR 1.3-6.4) and 2.6 (0.8-5.4) person-years (PY) after SOT and HSCT, a total of 212/1656 (13%) and 75/992 (8%) persons developed cancer; SIR 3.61 (3.0-4.3) and 2.2 (1.6-3.0), resp.). SIR correlated with younger age and was highest for skin and haematological cancers for both types of transplantation. Within the cohort, cancer was associated with older age (adjusted incidence rate ratio > 50 vs ≤ 19 years, among SOT and HSCT: 9.4 (3.4-25.7) and 25.4 (5.1-126.0), resp.) and current elevated C-reactive protein (CRP) (≥ 10 vs < 10 mg/L: 2.5 (1.8-3.4) and 2.3 (1.4-3.9), resp.), but neither with prior cancer nor type of immunosuppressants.CONCLUSION: Rates of de novo or secondary cancers are elevated in both SOT and HSCT compared with the general population and mainly for skin and haematological cancers. Among transplant recipients, older age and current elevated CRP are risk factors.
AB - PURPOSE: Solid organ (SOT) and allogeneic haematopoietic stem cell (HSCT) transplant recipients have elevated risks of de novo or secondary cancer. We explored risk factors hereof.METHODS: Among SOT and HSCT between January 2004 and December 2014, standardised incidence ratio (SIR) of de novo/secondary cancer compared with the Danish population was determined and risk factors were identified using Poisson regression.RESULTS: During a median of 3.4 (IQR 1.3-6.4) and 2.6 (0.8-5.4) person-years (PY) after SOT and HSCT, a total of 212/1656 (13%) and 75/992 (8%) persons developed cancer; SIR 3.61 (3.0-4.3) and 2.2 (1.6-3.0), resp.). SIR correlated with younger age and was highest for skin and haematological cancers for both types of transplantation. Within the cohort, cancer was associated with older age (adjusted incidence rate ratio > 50 vs ≤ 19 years, among SOT and HSCT: 9.4 (3.4-25.7) and 25.4 (5.1-126.0), resp.) and current elevated C-reactive protein (CRP) (≥ 10 vs < 10 mg/L: 2.5 (1.8-3.4) and 2.3 (1.4-3.9), resp.), but neither with prior cancer nor type of immunosuppressants.CONCLUSION: Rates of de novo or secondary cancers are elevated in both SOT and HSCT compared with the general population and mainly for skin and haematological cancers. Among transplant recipients, older age and current elevated CRP are risk factors.
KW - Adult
KW - Cohort Studies
KW - Female
KW - Hematopoietic Stem Cell Transplantation/adverse effects
KW - Humans
KW - Immunosuppressive Agents/adverse effects
KW - Incidence
KW - Male
KW - Middle Aged
KW - Neoplasms/etiology
KW - Neoplasms, Second Primary/etiology
KW - Organ Transplantation/adverse effects
KW - Risk Factors
KW - Transplant Recipients
KW - Young Adult
U2 - 10.1007/s00432-019-03039-2
DO - 10.1007/s00432-019-03039-2
M3 - Journal article
C2 - 31587105
VL - 145
SP - 3125
EP - 3135
JO - Zeitschrift fur Krebsforschung
JF - Zeitschrift fur Krebsforschung
SN - 0171-5216
IS - 12
ER -
ID: 236325568